These findings demonstrate that the beneficial effects of semaglutide treatment in this rodent model of CKD can occur separately from its anti-obesity and anti-diabetes effects.
Martinez et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: